Gilead Sciences Inc.Equity-NMS: GILD
Equity-NMS: GILD
$72.7
-0.31
(28 Feb)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$72.70
Open
$72.70
Today’s high
$73.25
Today’s low
$72.61
52W low
$71.37
52W high
$87.87
1Y
-6.24%
5Y
6.47%
PE
16.06
Div yield
4.00%
EPS (TTM)
4.50
Dividend
2.92
Shares O/S
1.25B
Market cap
90.57B
Insights
GILD has made a new 52 Wk low. 52 Wk low stocks tend to underperform in the near term.
GILD price is below its 200 day moving average
GILD PE is in the top end of its range over the past 2 years
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Gilead Sciences Inc.

Gilead Sciences, Inc. is a biopharmaceutical company. The Company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company offers products in HIV, Onocolgy, Liver Disease, Vekulaery, and Other. Under HIV, it offers Biktarvy, Complera/Eviplera, Genvoya, Odefsey, Stribild, and Truvada.

Its Veklury (remdesivir) is a nucleotide analog RNA polymerase inhibitor indicated for the treatment of coronavirus disease 2019 (COVID-19). Under oncology it offers cell therapy containing Tecartus and Yescarta. Under this Liver Disease consists of Chronic hepatitis C virus (HCV) (Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir) and Chronic hepatitis B virus (HBV) / hepatitis delta virus (HDV) (Vemlidy and Viread). The Company's other products include AmBisome and Letairis. It also operates a portfolio of small molecule inhibitors targeting PARP1 for oncology and MK2 for inflammatory diseases. .


FAQs

Can I buy Gilead Sciences Inc. shares in India?
How to buy Gilead Sciences Inc. shares in India?
What is the share price of Gilead Sciences Inc.?
What is the Market Capitalization of Gilead Sciences Inc.?
What is the PE ratio of Gilead Sciences Inc.?
Is Gilead Sciences Inc. a good stock to buy?
In which sector / industry does Gilead Sciences Inc. operate?